Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

In this slide presentation, Stephen Williams details using biomarkers to determine when to biopsy and when to repeat a prostate biopsy specifically: PSA, PHI, 4K, PCA3 and Confirm MDx. He overviews the patient journey pre and post biopsy and the process of determining which patients need a rebiopsy.


Stephen B. Williams, MD Assistant Professor in Urology, Tenure-Track, Robert Earl Cone Professorship, Director of Urologic Oncology, Director of Urologic Research, Co-Director Department of Surgery Clinical Outcomes Research Program